5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1)

5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) Struktur
64372-43-6
CAS-Nr.
64372-43-6
Englisch Name:
5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1)
Synonyma:
Citalopram Impurity 6;Escitalopram impurity 14;3-[(1RS)-5-Bromo-1-(4-fluorophenyl);Citalopram Related Compound H as Oxalate;Citalopram EP Impurity F (Oxalate salt form);Citalopram USP Related Compound H as Oxalate;Citalopram Hydrobromide EP Impurity F as Hydrogen Oxalate;5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1);3-[(1RS)-5-bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran- 1-yl]-N,N-dimethylpropan-1-amine;3-[(1RS)-5-bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran- 1-yl]-N,N-dimethylpropan-1-amine oxalate
CBNumber:
CB92717604
Summenformel:
C21H23BrFNO5
Molgewicht:
468.3134232
MOL-Datei:
64372-43-6.mol

5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) Eigenschaften

Schmelzpunkt:
148-150℃ (acetone )

Sicherheit

5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
sales@bjcomparison.com China 4749 58
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
2880679888@qq.com China 2812 58
Shenzhen SUNGENING Bio-Medical Co., Ltd. 0755-28967200 13631290199
wxf@sungening.com China 9592 60
Wuxi Helen Biotechnology Co., Ltd., 0510-85629785 18013409632
sales@reading-chemicals.com China 14092 58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd 17316404525
209533805@qq.com China 9640 58

  • 5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1)
  • Citalopram EP Impurity F (Oxalate salt form)
  • Citalopram Impurity 6
  • 3-[(1RS)-5-Bromo-1-(4-fluorophenyl)
  • 3-[(1RS)-5-bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran- 1-yl]-N,N-dimethylpropan-1-amine
  • 3-[(1RS)-5-Bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine Hydrogen Oxalate
  • Citalopram Related Compound H as Oxalate
  • Citalopram Hydrobromide EP Impurity F as Hydrogen Oxalate
  • Citalopram USP Related Compound H as Oxalate
  • Escitalopram impurity 14
  • 3-[(1RS)-5-bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran- 1-yl]-N,N-dimethylpropan-1-amine oxalate
  • 64372-43-6
  • C19H21BrFNOC2H2O4
Copyright 2019 © ChemicalBook. All rights reserved